The discussion festival titled “Just” recently convened to address the critical topic of clinical trials, drawing participation from key medical institutions and patient advocacy groups. The event was hosted at the National Cancer Center of the University Hospital of the Lithuanian University of Health Sciences (NVC) and involved representatives from the National Institute of Oncology (NVI), alongside patient organization members. The importance of these research avenues was highlighted through the experience of Raminta Vilkevičienė, a member of the Association “Blood.” Vilkevičienė shared that her understanding of the necessity of clinical research stems from her personal medical journey.
Sixteen years ago, she was diagnosed with acute lymphoblastic leukemia, a condition requiring approximately seven years of intensive treatment. After facing two significant recurrences in Lithuania, local treatment options were exhausted. In a situation where time was critical, Vilkevičienė took the initiative to seek advanced treatment opportunities abroad.
She was ultimately included in a treatment program in London for a medication that was already progressing through the second phase of clinical trials. The festival underscored the vital connection between robust national research infrastructure and the timely access patients have to cutting-edge therapies. The participation of leading national cancer centers and patient advocates emphasized the collective effort required to bridge the gap between the development of novel treatments and their availability to patients across the country.
Topics: #clinical #trials #national
